Where’s Capricor Therapeutics Inc (NASDAQ: CAPR) Headed This Year?

July 28, 2021

Capricor Therapeutics Inc (NASDAQ: CAPR), the biotechnology company, is focused on developing transformative exosome & cell-based therapies for treating and preventing a broad spectrum of diseases. In March 2021, the company announced that it is collaborating with Lonza for manufacturing and developing CAP-1002 to treat Duchenne muscular dystrophy, among other indications.  What’s ahead for CAPR? This year, the company has also signed an exclusive agreement with the JHU, or Johns…

Read More >>